Coverage
-
July 03, 2023
An Arizona federal judge has decided that a license agreement Bard signed with a medical device company that sells vascular stents can't be enforced after the patent's expiration date, labeling Bard's $52.8 million lawsuit against the company a clear case of "patent misuse."
1 other articles on this case.
View all »